These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24192094)

  • 61. The efficacy of 2002 CDC guidelines in preventing perinatal group B Streptococcal vertical transmission: a prospective study.
    Lijoi D; Di Capua E; Ferrero S; Mistrangelo E; Giannattasio A; Morano S; Ragni N
    Arch Gynecol Obstet; 2007 May; 275(5):373-9. PubMed ID: 17047973
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immunological characterization of mothers of infants with neonatal GBS infection: definition of a risk group.
    Christensen KK; Christensen P
    Antibiot Chemother (1971); 1985; 35():190-3. PubMed ID: 3901895
    [No Abstract]   [Full Text] [Related]  

  • 63. [Prevalence of the colonization by Streptococcus agalactiae in pregnant women from a maternity in Ceará, Brazil, correlating with perinatal outcomes].
    Linhares JJ; Cavalcante Neto PG; Vasconcelos JL; Saraiva Tde V; Ribeiro AM; Siqueira TM; Rocha FR
    Rev Bras Ginecol Obstet; 2011 Dec; 33(12):395-400. PubMed ID: 22282027
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Evaluation of 6 years of group B streptococcus (GBS) screening in near-term pregnant women].
    Honderlick P; Gravisse J; Cahen P; Vignon D
    Pathol Biol (Paris); 2010 Apr; 58(2):144-6. PubMed ID: 19892482
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Group B streptococcus prevalence in pregnant women from North-Eastern Italy: advantages of a screening strategy based on direct plating plus broth enrichment.
    Busetti M; D'Agaro P; Campello C
    J Clin Pathol; 2007 Oct; 60(10):1140-3. PubMed ID: 17182659
    [TBL] [Abstract][Full Text] [Related]  

  • 66. High prevalence of Streptococcus agalactiae from vaginas of women in Taiwan and its mechanisms of macrolide and quinolone resistance.
    Lee WT; Lai MC
    J Microbiol Immunol Infect; 2015 Oct; 48(5):510-6. PubMed ID: 24767417
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1996 May; 45(RR-7):1-24. PubMed ID: 8637497
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A systematic review of maternal TORCH serology as a screen for suspected fetal infection.
    Fitzpatrick D; Holmes NE; Hui L
    Prenat Diagn; 2022 Jan; 42(1):87-96. PubMed ID: 34893980
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Type-specific serum antibodies against group B streptococci among pregnant women: relation to urogenital carriage and age.
    Lindén V; Christensen KK; Christensen P
    Scand J Infect Dis; 1982; 14(3):189-93. PubMed ID: 6755658
    [No Abstract]   [Full Text] [Related]  

  • 70. The association of ToRCH infection and congenital malformations: A prospective study in China.
    Wang Y; Li S; Ma N; Zhang Q; Wang H; Cui J; Wang S
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():336-340. PubMed ID: 31382146
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The usefulness of determination of the procalcitonin (PCT) concentration in GBS piositive pregnant womens blood serum for anticipations of infections in newborns.
    Cnota W; Mucha D; Mucha J
    Przegl Epidemiol; 2018; 72(1):25-32. PubMed ID: 29667377
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Congenital and perinatal infections in the Marche region (Italy): an epidemiological study and differences between ethnic groups].
    Ruffini E; Compagnoni L; Tubaldi L; Infriccioli G; Vianelli P; Genga R; Bonifazi V; Dieni A; Guerrini D; Basili G; Salvatori P; DeColli R; Leone L; Gesuita R
    Infez Med; 2014 Sep; 22(3):213-21. PubMed ID: 25269963
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A predicting model of child-bearing-aged women' spontaneous abortion by co-infections of TORCH and reproductive tract.
    Zuo Q; Gao Z; Cai L; Bai L; Pei Y; Liu M; Xue H; Xu J; Wang S
    Congenit Anom (Kyoto); 2022 Jul; 62(4):142-152. PubMed ID: 35322463
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Importance of Functional Assessment of Immunity against Group B Streptococcus.
    Lee H
    J Korean Med Sci; 2018 Apr; 33(16):e129. PubMed ID: 29651822
    [No Abstract]   [Full Text] [Related]  

  • 75. Perinatal 'TORCH' infections identified by serology: correlation with abnormalities in the children through 7 years of age.
    Sever JL; Ellenberg JH; Ley AC; Madden DL; Fuccillo DA; Tzan NR; Edmonds DM
    Int J Epidemiol; 1992 Apr; 21(2):285-92. PubMed ID: 1428482
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Seroprevalence of ToRCH Pathogens in Southeast Asia.
    Fuchs FE; Pauly M; Black AP; Hübschen JM
    Microorganisms; 2021 Mar; 9(3):. PubMed ID: 33799699
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Systemic infections in obstetrics].
    Mylonas I; Gingelmaier A; Friese K
    Gynakologe; 2006; 39(3):223-232. PubMed ID: 32214435
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Torch screening reassessed-the laboratory investigation of congenital, perinatal and neonatal infection : Public health laboratory service (PHLS) 61 colindale avenue, London NW9 5DF, U.K.
    Verma IC
    Indian J Pediatr; 1991 Jul; 58(4):557. PubMed ID: 28326504
    [No Abstract]   [Full Text] [Related]  

  • 79. Passing the Torch.
    Duncombe C
    J Int Assoc Provid AIDS Care; 2021; 20():23259582211047797. PubMed ID: 34730460
    [No Abstract]   [Full Text] [Related]  

  • 80. Accepting the Torch.
    Fass R
    J Clin Gastroenterol; 2017 Jan; 51(1):1. PubMed ID: 27941582
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.